Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk. (Q55259913)
Jump to navigation
Jump to search
scientific article published on 5 April 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk. |
scientific article published on 5 April 2018 |
Statements
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk (English)
David S H Bell